Â¥
9.46
Jan 5
New Key Statistics Module, Z-Score and F-Score
SZSE:300434 Key Ratios
Market Cap ¥ M | 3,800.50 |
Enterprise Value ¥ M | 2,684.55 |
P/E(ttm) | 94.60 |
PE Ratio without NRI | 43.59 |
Forward PE Ratio | -- |
Price/Book | 1.57 |
Price/Sales | 3.51 |
Price/Free Cash Flow | 73.91 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.51 |
Revenue (TTM) ¥ M | 1,138.00 |
EPS (TTM) ¥ | 0.10 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -73.90 |
EV-to-EBIT | 30.80 |
EV-to-EBITDA | 30.80 |
PEG | -- |
Shares Outstanding M | 401.74 |
Net Margin (%) | 4.00 |
Operating Margin % | 14.83 |
Pre-tax Margin (%) | 7.72 |
Quick Ratio | 2.67 |
Current Ratio | 3.31 |
ROA % (ttm) | 1.53 |
ROE % (ttm) | 1.88 |
ROIC % (ttm) | 3.61 |
Dividend Yield % | 1.16 |
Altman Z-Score | 5.68 |
SZSE:300434 Number of Guru Trades
SZSE:300434 Volume of Guru Trades
Gurus Latest Trades with SZSE:300434
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300434 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sichuan Goldstone Asia Pharmaceutical Inc Insider Transactions
No Available Data